A Study of IBI3032 in Chinese Healthy Subjects
Clinical trial NCT07134127 · COMPLETED
Trial details
- NCT number
- NCT07134127
- Sponsor
- Innovent Biologics Technology Limited (Shanghai R&D Center)
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2025-10-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.